← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications (1203)

• Assessing disability progression using the WHODAS 2.0 in multiple sclerosis: Investigating clinical and socio-demographic factors in a large longitudinal cohort study (TONiC-MS). (2025/01/01) ♡
• Tumour necrosis factor-like weak inducer of apoptosis participates in the development of cutaneous fibrosis in an experimental systemic sclerosis model. (2025/01/01) ♡
• Exploring the Potential of Immersive Virtual Reality (VR) as a tool to enhance cognitive functions and alleviate clinical symptoms in Multiple Sclerosis (MS): Enhancing Cognitive Functions in Multiple Sclerosis Using Virtual Reality. (2025/01/01) ♡
• Evaluation of myelin content in the spinal cord of patients with multiple sclerosis: A positron emission tomography study. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New potential ligand-receptor axis involved in tissue repair as therapeutic targets in progressive multiple sclerosis. (2025/01/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Coenzyme Q10 supplementation in multiple sclerosis; A systematic review. (2025/01/01) ♡
• Comparison of practice-related changes in dual task walking performance and neural efficiency between older adults with progressive and relapsing-remitting multiple sclerosis. (2025/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications. (2025/01/01) ♡
• Factors affecting fatigue progression in multiple sclerosis patients. (2024/12/30) ♡
• A 50-year data-driven model of disability and lesion load trajectories in progressive multiple sclerosis. (2024/12/27) ♡
• Prognostic Value of CXCL13, CCL11, and CCL20 Chemokines in Multiple Sclerosis. (2024/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Marburg variant of multiple sclerosis: A young women case report. (2024/12/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases. (2024/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rationale for phosphodiesterase-4 inhibition as a treatment strategy for interstitial lung diseases associated with rheumatic diseases. (2024/12/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bilateral Reversible Corneal Edema as a Novel Side-Effect of Levetiracetam - A Case Report. (2024/12/23) ♡
• Selective retinoid X receptor agonism promotes functional recovery and myelin repair in experimental autoimmune encephalomyelitis. (2024/12/21) ♡
• Workplace and social support, treatment satisfaction, and their impact on quality of life in Swedish women with multiple sclerosis: a cross-sectional survey study. (2024/12/20) ♡
• Barriers to clinical follow-up visits in multiple sclerosis: A nationwide register-based study. (2024/12/18) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Combined Use of Intranasal Methylprednisolone and Allopregnanolone: Revisiting Anti-inflammatory and Remyelinating Treatment in a Murine Model of Multiple Sclerosis. (2024/12/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Brain organoid methodologies to explore mechanisms of disease in progressive multiple sclerosis. (2024/12/18) ♡
• In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis. (2024/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploring the Role of Axons in ALS from Multiple Perspectives. (2024/12/17) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role and Diagnostic Significance of Apolipoprotein D in Selected Neurodegenerative Disorders. (2024/12/14) ♡
• Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis. (2024/12/13) ♡
• Signatures of chronic pain in multiple sclerosis: a machine learning approach to investigate trigeminal neuralgia. (2024/12/13) ♡
• Dysphagia in multiple sclerosis: pathophysiology, assessment, and management-an overview. (2024/12/13) ♡
• Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis. (2024/12/12) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Azathioprine for people with multiple sclerosis. (2024/12/09) ♡
• Acceptability and Feasibility of the English Version of Elevida, a Self-Guided Online Fatigue Intervention for People With Multiple Sclerosis. (2024/12/09) ♡
• Relationship Between T-helper 1 Inflammatory Biomarkers and Hematological Index Responses in Patients With Multiple Sclerosis. (2024/12/07) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials. (2024/12/06) ♡
• P2X (7)-receptor binding in new-onset and secondary progressive MS - a [(11)C]SMW139 PET study. (2024/12/05) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis. (2024/12/05) ♡
• Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trial. (2024/12/05) ♡
• Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome. (2024/12/05) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Co-Existent Central and Peripheral Demyelination: Related or Coincidental? (2024/12/03) ♡
• A data-driven model of disability progression in progressive multiple sclerosis. (2024/12/03) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy. (2024/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report. (2024/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Idiopathic Multiple Localized Lipoatrophy Mimicking Amyotrophic Lateral Sclerosis. (2024/12/01) ♡
• Analysis of Immunological Memory for John Cunningham Virus in a Mexican Population of Patients with Multiple Sclerosis Under Treatment. (2024/11/29) ♡
• Alexithymia and attachment on mental health of people with multiple sclerosis: The mediating role of perceived social support and loneliness. (2024/11/29) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. New-Onset Multiple Sclerosis in Pregnancy: Diagnostic Approaches and Treatment Dilemmas. (2024/11/28) ♡
• Patterns and predictors of multiple sclerosis phenotype transition. (2024/11/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Concomitant Amyotrophic Lateral Sclerosis and Rheumatoid Arthritis: A Case Report. (2024/11/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Relevance of Saliva Analyses in Terms of Etiological Factors, Biomarkers, and Indicators of Disease Course in Patients with Multiple Sclerosis-A Review. (2024/11/22) ♡
• Smartphone Postural Sway and Pronator Drift tests as Measures of Neurological Disability. (2024/11/21) ♡
• Barriers for work in people with multiple sclerosis: a Norwegian cultural adaptation and validation of the short version of the multiple sclerosis work difficulties questionnaire. (2024/11/20) ♡
• A Clinical Care Algorithm for Detecting Progression in Multiple Sclerosis: RetratEMos Project. (2024/11/19) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial. (2024/11/18) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.